O-GlcNAcylation promotes migration and invasion in human ovarian cancer cells via the RhoA/ROCK/MLC pathwayYichao Niu, Xiaofei Shi|Molecular Medicine Reports|2017Cited by 33
Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trialJinjing Liu, Xiaofeng Zeng, Shangzhu Zhang et al.|Annals of the Rheumatic Diseases|2025Cited by 17